Pilot Test of Innovative Child Maltreatment (CM) Prevention Strategy

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Apr 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to deliver the SafeCare program, which helps prevent child maltreatment by providing support to families. Millions of children face maltreatment each year in the U.S., and SafeCare has been effective in helping families, but it often struggles to reach those who need it most. This trial will look at how well a mix of in-person and virtual visits works, involving 12 home visiting providers and 40 caregivers, to improve access to these important services and better support families.

To participate in the trial, caregivers must be at least 18 years old, speak English, and have at least one child aged 0-5. They also need to have completed part of the SafeCare program since April 2021 and not be currently enrolled in it. Home visiting providers must be fully certified and have been providing SafeCare services for at least six months. While the study is not yet recruiting participants, it aims to gather valuable information on how to effectively offer SafeCare to more families, ultimately helping to protect children from harm.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • At least 18 years old
• • English language proficiency
• • Ability to provide informed consent for themselves
• • Has at least one child between the ages of 0-5 years old - Caregivers Only
• • Has completed at least 1 module of SafeCare since April 2021 - Caregivers Only
• • SafeCare enrollment has been completed (e.g., not currently enrolled in SafeCare). - Caregivers Only
• • Current employment at a SafeCare agency - Agency Leaders Only
• • Full- or part-time employment at a SafeCare agency - Providers Only
• • Must be fully certified to provide SafeCare services - Providers Only
• • Must be providing services for at least 6 months - Providers Only
• Exclusion Criteria:
• • Evidence of significant cognitive disability, developmental delay, or pervasive developmental disorder that would prohibit capacity to consent for themselves - Caregivers Only
• • There are no primary exclusion criteria for the Providers.
• • There are no primary exclusion criteria for Agency Leaders.